Yüklüyor......
The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis
OBJECTIVES: To investigate the efficacy and safety of Bevacizumab (Bev) used in combination with paclitaxel and carboplatin (PC), compared with PC alone in patients with advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: We searched the PubMed, EMBASE, Cochrane Central Register of C...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865694/ https://ncbi.nlm.nih.gov/pubmed/29581868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23657 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|